- PDB-5vp1: Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluorom... -
+
データを開く
IDまたはキーワード:
読み込み中...
-
基本情報
登録情報
データベース: PDB / ID: 5vp1
タイトル
Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders
ジャーナル: Chem. Pharm. Bull. / 年: 2017 タイトル: Discovery of a Novel Series of Pyrazolo[1,5-a]pyrimidine-Based Phosphodiesterase 2A Inhibitors Structurally Different from N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl) ...タイトル: Discovery of a Novel Series of Pyrazolo[1,5-a]pyrimidine-Based Phosphodiesterase 2A Inhibitors Structurally Different from N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), for the Treatment of Cognitive Disorders. 著者: Mikami, S. / Kawasaki, M. / Ikeda, S. / Negoro, N. / Nakamura, S. / Nomura, I. / Ashizawa, T. / Kokubo, H. / Hoffman, I.D. / Zou, H. / Oki, H. / Uchiyama, N. / Hiura, Y. / Miyamoto, M. / ...著者: Mikami, S. / Kawasaki, M. / Ikeda, S. / Negoro, N. / Nakamura, S. / Nomura, I. / Ashizawa, T. / Kokubo, H. / Hoffman, I.D. / Zou, H. / Oki, H. / Uchiyama, N. / Hiura, Y. / Miyamoto, M. / Itou, Y. / Nakashima, M. / Iwashita, H. / Taniguchi, T.
構造決定の手法: 分子置換 / 解像度: 1.86→30 Å / Cor.coef. Fo:Fc: 0.952 / Cor.coef. Fo:Fc free: 0.94 / WRfactor Rfree: 0.2264 / WRfactor Rwork: 0.2079 / FOM work R set: 0.7542 / SU B: 10.017 / SU ML: 0.141 / SU R Cruickshank DPI: 0.1813 / SU Rfree: 0.1494 / 交差検証法: THROUGHOUT / σ(F): 0 / ESU R: 0.181 / ESU R Free: 0.149 / 立体化学のターゲット値: MAXIMUM LIKELIHOOD 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS U VALUES : WITH TLS ADDED
Rfactor
反射数
%反射
Selection details
Rfree
0.2433
4114
4.8 %
RANDOM
Rwork
0.2245
-
-
-
obs
0.2254
80761
98.58 %
-
溶媒の処理
イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å / 溶媒モデル: MASK